Financial Summary for the Fiscal Year Ending December 2025 [Japanese GAAP] (Consolidated)

Overview of Results

For the fiscal year ending December 2025, consolidated net sales were ¥85,071 million (3.8% decrease YoY), operating income was ¥16,638 million (13.4% decrease YoY), ordinary income was ¥16,699 million (13.5% decrease YoY), and net income attributable to owners of parent was ¥11,761 million (19.0% decrease YoY). The Imaging-related segment saw increased revenue with new product launches in Japan, U.S., and India, but decreased revenue due to a rebound decline in China and lower OEM shipments. The Surveillance & FA segment experienced a slight decrease in sales but improved profitability resulting in increased operating income. The Mobility & Healthcare segment recorded both sales and profit growth. Foreign exchange impact included approximately 2 yen appreciation of the yen against USD and approximately 5 yen depreciation against EUR.

Outlook

For the fiscal year ending December 2026, the Company plans net sales of ¥91 billion (7.0% increase YoY), operating income of ¥18.5 billion (11.2% increase YoY), ordinary income of ¥18.5 billion (10.8% increase YoY), and net income attributable to owners of parent of ¥13.6 billion (16.4% increase YoY). This assumes increased launches of new models of mirrorless camera interchangeable lenses, recovery in demand for FA camera lenses, and sustained strong performance in automotive and medical lens businesses. Foreign exchange assumptions are 1 USD = ¥148 and 1 EUR = ¥175. Although uncertainties remain from geopolitical risks and concerns over China’s economic slowdown, a general moderate recovery trend is expected.